Chapter 38 — The Art of Synthesis: Retrosynthetic Thinking, Strategy, and the Beauty of Total Synthesis

"Total synthesis is the highest art of organic chemistry. To take a complex natural product — say, taxol, or cobalamin, or strychnine — and build it from scratch from simple starting materials in a sequence of mechanistically-defined steps, with stereocontrol at every center, is to demonstrate that you understand chemistry deeply. The Nobel Prizes given to Woodward (1965), Corey (1990), and to Tu Youyou (2015) for artemisinin reflect the centrality of total synthesis to chemistry." — paraphrase from a synthesis history

"When I was a graduate student, my advisor handed me a published synthesis and said, 'Go reproduce this — it'll teach you organic chemistry better than any course.' He was right. Total synthesis is the integration of everything you've learned, applied to a real molecule of real importance."

This chapter is the capstone of the textbook. Every reaction, every framework, every principle from Parts I-VII converges here. We walk through: 1. The principles of total synthesis design (retrosynthesis, strategic bonds, convergence). 2. A complete case study of a real pharmaceutical: artemisinin (Tu Youyou's 2015 Nobel-winning antimalarial). 3. The history of total synthesis (Woodward, Corey, Nicolaou). 4. What "art" means in synthesis — and how to develop your own design intuition.

By the end of this chapter you should: - Be able to read and evaluate published total syntheses. - Understand what "elegance" means in synthesis. - Be ready to continue organic chemistry study at the graduate level or in industry. - See how each chapter of this textbook fits into the bigger picture of what chemistry can build.

38.1 The target: artemisinin

Artemisinin is a sesquiterpene endoperoxide produced by the sweet wormwood plant (Artemisia annua). It treats malaria — particularly chloroquine-resistant strains of Plasmodium falciparum. The discovery and development of artemisinin earned Tu Youyou the 2015 Nobel Prize in Physiology or Medicine, the first Chinese woman to win a Nobel.

Why artemisinin matters

• Malaria: ~250 million cases/year; ~600,000 deaths/year, mostly children in Africa. The number-one infectious disease killer in the world.
• Before artemisinin, chloroquine was the standard treatment. By the 1980s-1990s, chloroquine resistance was widespread.
• Artemisinin (and its derivatives) are now first-line treatment for malaria.

Tu Youyou's discovery

Tu Youyou (Chinese pharmacologist, born 1930) led "Project 523" — a Chinese government effort during the Vietnam War to find new antimalarials (Vietnamese and U.S. forces were both being decimated by malaria). Searching traditional Chinese medicine literature, Tu rediscovered Ge Hong's 4th-century recipe for qinghao (Artemisia annua). She extracted the active component (artemisinin) and proved its antimalarial activity.

Artemisinin was isolated in 1972; the structure determined in 1979; total synthesis achieved in the 1980s.

Structure

Artemisinin (C₁₅H₂₂O₅) has: - A 6-6-6 fused ring system with three fused 6-membered rings. - An endoperoxide bridge (O-O within a ring) — rare in natural products, essential for activity. - A lactone (cyclic ester) at one end. - Multiple stereocenters (7 total). - A methyl group at a key position.

The endoperoxide is the pharmacophore: in malaria parasites (which have iron-rich heme), the endoperoxide is reduced (homolytically), generating a free radical that destroys parasite cells.

38.2 Retrosynthetic analysis of artemisinin

The total synthesis problem: given artemisinin's structure, design a route from commercially available starting materials. Strategic disconnections:

Disconnection 1: The endoperoxide

The O-O bond is unusual — it can be installed by singlet oxygen [4+2] cycloaddition with a 1,3-diene. The retro-disconnection: artemisinin → 1,3-diene + ¹O₂.

This is a clever strategic disconnection. It postpones the endoperoxide installation until late in the synthesis (when the rest of the molecule is built). Singlet oxygen [4+2] is one of the few ways to make an endoperoxide; the diene must be set up correctly to give the right regiochemistry.

Disconnection 2: The lactone

The lactone is a cyclic ester. Disconnect it: lactone → hydroxy acid (open-chain). Forward: Fischer esterification or acyl substitution-style cyclization.

Disconnection 3: The fused 6-6 ring

A trans-fused 6-6 ring system is the decalin skeleton. The most strategic disconnection is by Diels-Alder: ring A + B → diene + dienophile. With suitable substrates, the Diels-Alder gives a fused 6-6 system in one step.

Alternatively: Robinson annulation — Michael + intramolecular aldol — to build the second ring on top of the first.

Disconnection 4: Set the chirality early

Artemisinin's first stereocenter (the C5 quaternary carbon) is the most challenging. Several strategies: - Use a chiral starting material (e.g., (+)-citronellal, a commercial chiral terpene) to set the chirality at the start. - Use an asymmetric reaction (Sharpless, Noyori, etc.) at a key step. - Use a chiral auxiliary (Evans, Crimmins) and remove it after.

Convergent strategy

A convergent synthesis builds two halves and joins them: - Fragment A: the western part (rings A and B) — from a chiral starting material. - Fragment B: the eastern part (ring C and the lactone) — from a different starting material. - Coupling: a strategic C-C bond formation (aldol, Heck, etc.).

A convergent synthesis is usually higher-yielding than a linear one.

38.3 The Schmid forward synthesis (1983, 14 steps)

Schmid's classic synthesis (from a chemical engineer's perspective):

1. Start with (+)-citronellal (a C₁₀ commercial terpene; sets chirality at C5).
2. Aldol-style condensation to extend the chain.
3. Several functional group manipulations and ring-formation steps to build the 6-6 fused ring system.
4. Lactonization to install the lactone.
5. Singlet oxygen [4+2] at a late stage to install the endoperoxide.
6. Final purification.

Total: 14 steps. Yield: ~5% overall (modest). Works well in research scale but not for industrial production.

The synthesis used: - Aldol (Ch 28). - Robinson annulation-style chemistry (Ch 29). - Asymmetric reduction (Ch 36). - Singlet oxygen [4+2] (Ch 19, the Diels-Alder logic, applied to ¹O₂). - Fischer esterification (Ch 26). - Various oxidations and reductions (Ch 36).

Every chapter from Parts I-VIII is involved.

38.4 The Lebreton synthesis (2008, 8 steps)

A more recent synthesis (Lebreton et al., 2008) achieves artemisinin in 8 steps from (+)-citronellal. Improvements: - More convergent strategy. - Pd-catalyzed coupling for one of the C-C bond formations. - Higher overall yield (~10%).

The chemistry is similar to Schmid's but with modern methods (Pd cross-coupling, asymmetric methods, fewer protecting group manipulations).

38.5 Industrial production: extraction + semi-synthesis

Despite total syntheses, artemisinin is produced industrially mostly by: - Plant extraction: harvest sweet wormwood; extract artemisinin in a solvent. Cost-effective for moderate quantities. - Semi-synthesis: extract a precursor (e.g., artemisinic acid) from genetically engineered yeast; then chemically convert artemisinic acid → artemisinin.

The semi-synthesis: artemisinic acid + various oxidations + singlet oxygen → artemisinin.

This is the most economical route. Sanofi has produced artemisinin via engineered yeast since 2013 (cost ~$200/kg), feeding the production of artemisinin combination therapies (ACTs) for malaria.

The biotechnology approach (engineered yeast to make artemisinic acid) was an Open-Source effort by Jay Keasling and the OneWorldHealth foundation. Won "TIME magazine's 100 Best Inventions" in 2010.

38.6 The principles of total synthesis design

Principle 1: Identify strategic bonds

Look at the target. Where are the bonds that, if broken, would reveal substantially simpler precursors? These are the strategic disconnections. They are usually: - C-C bonds between functional groups (aldol, Claisen, Michael, Pd cross-coupling). - C-N bonds (amide, amine). - C-O bonds (ester, ether). - Ring closures (especially for medium rings).

Principle 2: Plan stereochemistry early

If the target has multiple stereocenters, plan how to set each one. Options: - Chiral pool: start with a chiral starting material (amino acids, sugars, terpenes). - Asymmetric methods: Sharpless, Noyori, Knowles, Evans aldol, etc. - Diastereoselective reactions: pre-existing stereocenters direct the next center.

For complex molecules, set the most challenging stereocenter first; subsequent ones follow.

Principle 3: Use convergent synthesis

A convergent synthesis (two halves built separately, then joined) is preferred over linear. The "key disconnection" should split the molecule into two roughly-equal halves. This: - Gives higher overall yield (multiplicative effects of yield are halved). - Allows parallel work on different halves. - Enables easier troubleshooting.

Principle 4: Minimize protecting groups

Each protecting group adds 2 steps (protect + deprotect). Choose strategies that minimize them. If a reaction can be done without protection, do it. If protection is required, use orthogonal protecting groups so they can be removed selectively.

Principle 5: Use known reactions when possible

Reinventing chemistry costs time. Use the named reactions (Aldol, Claisen, Suzuki, Heck, RCM, etc.) as your toolkit. Combine them in new ways.

Principle 6: Test the route on a model substrate

Before committing to the full synthesis, test the key step(s) on a model substrate. This catches problems early.

Principle 7: Optimize step-by-step

Once you have a working synthesis, optimize: improve yields, reduce step counts, switch to more efficient reagents. Modern industrial syntheses go through many iterations.

38.7 Historical masters of total synthesis

Robert B. Woodward (1917-1979, Nobel 1965)

Woodward is universally recognized as the greatest synthetic chemist of the 20th century. Major syntheses: - Quinine (1944, with Doering): the first total synthesis of an alkaloid. - Cortisone, cholesterol (1951): the first total syntheses of steroids. - Strychnine (1954): one of the most complex molecules synthesized to date at that time. - Reserpine (1956): an important natural product alkaloid. - Chlorophyll a (1960): the green pigment of plants. - Vitamin B12 (cobalamin) (1972, with Eschenmoser): a 90-step synthesis of one of the most complex natural products.

Woodward's contributions also include the Woodward-Hoffmann rules (for pericyclic reactions, Ch 39).

E. J. Corey (1928-2025, Nobel 1990)

Corey developed: - Total synthesis methodology: many natural products. - Retrosynthetic analysis: the systematic approach to design. - The CBS reagent: asymmetric ketone reduction. - Many named reactions: Corey-Bakshi-Shibata reduction, Corey-Chaykovsky reaction, Corey-Fuchs alkyne synthesis, Corey-Winter olefination, etc.

His book The Logic of Chemical Synthesis defined modern retrosynthesis.

K. C. Nicolaou (1946-)

Nicolaou is one of the most prolific modern synthetic chemists. Major syntheses: - Taxol (paclitaxel) (1994): the anticancer natural product. A 47-step synthesis. - Vancomycin (1999): the antibiotic. - Brevetoxin B (1998): a marine natural product with 11 fused rings. - Many other complex natural products.

His textbook Classics in Total Synthesis is the modern reference.

Other notables

• Samuel Danishefsky (1936-): epothilones, calicheamicin, etc.
• David Evans (1941-2022): the Evans chiral auxiliary; many natural products.
• Larry Overman (1943-): aspidospermine, strychnos alkaloids.
• Phil Baran (1977-): modern total syntheses with elegant strategies (e.g., welwitindolinone).
• Stuart Schreiber, Eric Jacobsen, Erick Carreira, others: many major contributors.

38.8 The state of the art

Modern total synthesis (2020s) features: - AI-guided synthesis (Synthia, IBM RXN): automated retrosynthesis. - Flow chemistry: continuous synthesis at scale. - Biocatalysis: enzymes for stereoselective steps. - Photoredox catalysis: light-driven reactions for novel disconnections. - C-H activation: late-stage functionalization. - Targeted protein degradation chemistry (PROTACs): new pharmacophores.

The current generation of synthetic chemists has tools that Woodward couldn't have imagined. Yet the basic logic — retrosynthesis, strategic bonds, convergent design — remains the same.

38.9 What "art" means in synthesis

Total synthesis is called art because:

1. Design choices: many synthesis routes work; choosing the best one requires judgment.
2. Elegance: shorter routes with fewer protecting groups are more "elegant."
3. Surprise: unexpected disconnections (e.g., late-stage Diels-Alder) are aesthetically pleasing.
4. Stereocontrol: achieving specific stereochemistry is satisfying.
5. Efficiency: high yield + few steps.
6. Scalability: a synthesis that can be made into a process.
7. Connection to biology: synthesizing a natural product validates the structure.

The greatest syntheses combine all of these. Studying them is both an education and an aesthetic experience.

38.10 Looking forward

What's next in synthesis?

1. AI integration: AI proposes routes; chemists evaluate.
2. Automation: lab robots execute syntheses.
3. Greener methods: continuous flow, less waste, biocatalysis.
4. New chemistry: photoredox, electrochemistry, C-H activation.
5. Drug-like molecule design: PROTACs, molecular glues, ADCs.
6. Personalized medicine: tailoring drugs for individuals.

The next decades will see synthesis become faster, more efficient, more sustainable. The chemistry of this textbook is the foundation.

38.11 What you are ready for

After this textbook, you have the chemistry foundation for: - Graduate-level synthesis courses (most courses assume your textbook level). - Reading the primary literature (organic and medicinal chemistry). - Undergraduate research projects in synthesis. - Medicinal chemistry job entry with additional pharmacology training. - Industry process chemistry with additional engineering training. - Continuing self-education in chemistry.

The chemistry is yours. What you build with it is up to you.

38.12 Famous total syntheses

Strychnine: Woodward (1954)

Strychnine is a pentacyclic alkaloid; one of the most complex molecules ever synthesized at the time. Woodward's 1954 synthesis (28 steps) was a landmark in synthesis.

Key features: - Used Diels-Alder cycloaddition for ring formation. - Asymmetric synthesis without chiral catalysts (chiral pool starting material). - Stereocontrol at each step.

The synthesis spawned a generation of natural product chemists.

Vitamin B12: Woodward + Eschenmoser (1972)

Vitamin B12 (cyanocobalamin) is one of the most complex natural products with a corrin macrocycle. Woodward (Harvard) and Eschenmoser (ETH Zurich) collaborated; ~100 steps total. Took 11 years.

Most complex molecule synthesized at the time. The collaboration combined Woodward's unique synthetic insight with Eschenmoser's ring-construction chemistry. The synthesis demonstrated that total synthesis of any natural product was possible, given enough time.

Erythromycin A: Woodward (1981, posthumous)

A 14-membered macrolide antibiotic. Woodward died before completing it; his group finished. ~50 steps. Demonstrated key strategies: - Convergent fragmentation. - Templating to control stereochemistry. - Innovative reactions for ring closure.

Modern syntheses use RCM (Ch 37) for macrocyclic ring closure; much shorter than Woodward's classical approach.

Taxol: many groups (1994-1996)

Several groups raced to total synthesis of Taxol (paclitaxel), the cancer drug from yew tree: - Holton (Florida State). - Nicolaou (Scripps). - Wender (Stanford). - Mukaiyama (Tokyo).

Each route ~30+ steps; <1% overall yield. Taxol's industrial production now uses semi-synthesis from baccatin III (extracted from yew needles) — much more practical.

Brevetoxin B: Nicolaou (1995)

A complex marine natural product with 11 fused ether rings. Nicolaou's synthesis showcased modern synthetic methods (Suzuki, Heck, asymmetric oxidation). Took ~15 years.

Discodermolide: many groups (1996-2008)

A marine antitumor compound; multiple total syntheses. Demonstrated diverse strategies for the same target.

Carbohydrate-targeting drugs

The HIV protease inhibitor amprenavir; Tamiflu (oseltamivir; antiviral); each made by clever use of stereocenters from sugar starting materials.

These famous syntheses exemplify the art of synthesis — choosing strategies, designing routes, executing reactions with skill.

38.13 The chemistry of synthesis design

A total synthesis goes through several phases:

1. Target analysis

Examine the target molecule: - What is the molecular formula? - How many stereocenters? - What functional groups? - What ring systems? - Is the natural product chiral, racemic, or meso?

2. Retrosynthetic analysis

Apply Corey's retrosynthetic principles: - Strategic bonds: which bonds to break first? - Disconnections: corresponding bond-forming reactions. - Functional group interconversion (FGI): can we change one group to another? - Substrate availability: working back to commercial starting materials.

3. Forward synthesis design

Plan the actual sequence: - Order of steps (which functional groups to install first?). - Protection/deprotection (when needed). - Stereocontrol strategy. - Convergent vs linear?

4. Trial and error in the lab

Some steps work; many don't on first try. Modifications, alternatives, and creative problem-solving are essential.

5. Optimization

Once the route works, optimize: - Higher-yielding conditions for each step. - Greener reagents. - Scale-up considerations. - Final purification.

6. Scale-up

For pharmaceutical manufacturing: - Replace expensive reagents with cheaper. - Use heterogeneous catalysts (recyclable). - Optimize workup procedures. - Validate the process.

These phases are how synthesis is done in practice.

38.14 Modern frontiers in synthesis

AI-guided synthesis

Machine learning models (Chematica, IBM RXN, Synthia) propose synthesis routes: - Input: target structure. - Output: ranked list of synthesis routes. - Modern systems handle complex molecules better than any single human chemist.

These tools are now part of pharmaceutical R&D.

Flow chemistry

Continuous flow reactors: - Better thermal control. - Higher safety for hazardous reactions. - Scalability. - Real-time monitoring (NMR, HPLC inline).

Used for ozonolysis, photochemistry, hydrogenation, asymmetric catalysis.

Photoredox catalysis

Visible light + photocatalyst → radical intermediates. Enables new bond formations not possible by classical chemistry. Discovered ~2008-2010 (Yoon, MacMillan, Stephenson groups).

C-H activation

Direct functionalization of C-H bonds without prefunctionalization. Pd, Rh, Ir catalysts with directing groups. Late-stage diversification.

Biocatalysis

Engineered enzymes for asymmetric transformations: - Sitagliptin (Codexis transaminase, 2010). - Many other industrial uses. - High ee, often water solvent, mild conditions.

Computer-aided design

Rosetta, AlphaFold for protein design; computational tools for retrosynthesis; DFT for mechanism studies. Computational chemistry is integrated into modern synthesis.

38.15 The chemistry of nature: how natural products are biosynthesized

Many of the natural products that synthesis chemists target are made by enzymes:

Acetogenins (fatty acids and polyketides)

Acetyl-CoA + malonyl-CoA + fatty acid synthase → fatty acids. Polyketides (e.g., erythromycin's polyketide chain) are made similarly by polyketide synthases. Modular catalysts; can be engineered.

Terpenoids

Isoprene → terpenes via prenyltransferases (Ch 34). Cyclization by terpene cyclases gives the diverse terpenoid skeletons.

Alkaloids

Amino acids → alkaloids via various biosynthetic pathways. Strictosidine synthesis (catalyzed by strictosidine synthase) is the gateway to many indole alkaloids.

Aromatic compounds

Shikimate pathway: phosphoenolpyruvate + erythrose-4-phosphate → chorismate → many aromatic compounds (phenylalanine, tyrosine, tryptophan).

Complex natural products

Many are made by combining multiple pathways. Vitamin B12 is biosynthesized in bacteria via ~70 enzymes. Tetracycline is made by polyketide synthase + multiple modifications.

Engineered biosynthesis

Modern synthetic biology engineers organisms (typically E. coli or S. cerevisiae) to make natural products: - Artemisinic acid in yeast (Keasling, 2013): part of artemisinin synthesis. - Anti-cancer compounds: yeast or bacteria engineered to make drugs.

Combining engineered biosynthesis with classical organic synthesis is the future of natural product manufacturing.

38.16 The role of synthesis in society

Total synthesis: - Demonstrates that we can build any molecule (no longer "the molecule that defeated chemistry"). - Provides materials for biological studies: when natural sources are scarce. - Enables drug development: many drugs are based on natural products. - Develops new chemistry: each new synthesis often pioneers new reactions. - Educates chemists: a complex synthesis is a multi-disciplinary exercise.

The art of synthesis is the chemistry that makes the rest of organic chemistry possible. It's where all the methods come together.

38.17 Closing thought

The chemistry of this textbook is meant to give you the foundation for understanding (and creating) molecules. From acetylsalicylic acid (aspirin) to artemisinin to the complex molecules of the future, the same fundamental principles apply.

You've learned: - Bonding, structure, mechanism (Ch 1-9). - Substitution, elimination, addition (Ch 10-19). - Aromatic chemistry (Ch 20-23). - Carbonyl chemistry (Ch 24-31). - Bioorganic chemistry (Ch 32-35). - Advanced topics: oxidation/reduction, organometallic, art of synthesis, pericyclic, green chemistry (Ch 36-40).

Each topic builds on the previous. The whole framework lets you read modern chemistry literature, design syntheses, and continue learning chemistry on your own.

The chemistry is yours. What you build with it is up to you.

38.18 Synthesis case study: Tamiflu (oseltamivir)

Tamiflu (oseltamivir phosphate) is an anti-influenza drug; sold ~$3 billion/year peak sales (especially during pandemic threats). Its synthesis is a fascinating case study.

The molecule

Oseltamivir has: - A cyclohexene ring with 4 stereocenters. - An ethyl ester (the phosphate is a salt at the amine). - A carbamoyl-O-acetyl side chain. - Total: 4 stereocenters, all (R), and an alkene.

Roche's industrial synthesis

The original Roche synthesis used (-)-shikimic acid as starting material: - Shikimic acid is extracted from Chinese star anise. - ~12 steps, ~7-8% overall yield. - Several Pd-catalyzed and asymmetric steps.

This synthesis was key during the H5N1 (bird flu) and H1N1 (swine flu) pandemics — but limited by the supply of shikimic acid.

Biocatalytic alternative

In 2009, a synthesis using fermentation-produced shikimic acid was developed. E. coli engineered to overexpress shikimate dehydrogenase produces shikimic acid from glucose at large scale. This bypasses the star anise supply chain.

The challenges

• All 4 stereocenters must be installed correctly.
• Multiple Pd-catalyzed steps (Suzuki, Heck).
• Mitsunobu reaction for one stereocenter.
• Dehydration and acid-base chemistry for the alkene and amine.

Take-home

Tamiflu's synthesis exemplifies modern pharmaceutical chemistry: extract from plant, use biocatalysis, employ Pd cross-coupling, control all stereocenters carefully. ~$3 billion/year of sales.

38.19 Synthesis case study: Lipitor (atorvastatin)

Lipitor (atorvastatin) was the highest-selling drug of all time (peak: ~$13 billion/year, 2003-2010). Its synthesis is industrial chemistry at scale.

The molecule

Atorvastatin has: - A pyrrole ring with multiple substituents. - 2 stereocenters (both R). - A 3,5-dihydroxyheptanoic acid chain. - A 4-fluorophenyl group, phenyl, isopropyl, and an N-phenyl carboxamide.

Pfizer's industrial synthesis

Pfizer's synthesis is highly optimized: - Pyrrole ring formed via Paal-Knorr synthesis. - Stereocenters installed via biocatalytic reduction. - Both R stereocenters made with 99%+ ee using ketoreductase enzymes. - Several Pd-catalyzed steps for aryl-aryl bonds. - Final coupling and crystallization.

Annual production

At peak, Pfizer made ~$13 billion of Lipitor per year. The synthesis runs at multi-ton scale at Pfizer plants worldwide.

Patent loss and generics

Lipitor's patent expired in 2011; generic atorvastatin is now ~99% cheaper. Many generic manufacturers use similar (or modified) synthesis routes.

Take-home

Atorvastatin's synthesis combines: - Biocatalysis (ketoreductase for stereocontrol). - Pd cross-coupling (aryl-aryl bonds). - Classical organic chemistry (heterocycle formation).

This is modern industrial chemistry at its peak.

38.20 The art of synthesis: closing thoughts

Total synthesis is the apotheosis of organic chemistry. It requires:

• Knowledge of all the methods (Ch 10-37 of this book).
• Strategy (retrosynthesis, convergence, stereo planning).
• Skill in the lab (every step works only with practice).
• Creativity (designing routes, solving unexpected problems).
• Persistence (most steps don't work the first time).

The chemists who excel at total synthesis (Woodward, Corey, Stork, Eschenmoser, Nicolaou, Trost, and many others) are recognized as masters of organic chemistry. Their syntheses train the next generation of chemists.

The chemistry of this textbook gives you the toolkit. Total synthesis is what you can do with that toolkit.

38.21 The synthesis of new chemistry

Many syntheses don't just build target molecules; they pioneer new methods:

Diels-Alder application

Otto Diels and Kurt Alder (1928) discovered the cycloaddition that bears their name. Subsequent natural product syntheses by Woodward used Diels-Alder extensively. Woodward's reserpine synthesis (1956) used a Diels-Alder for ring formation; the elegance of the reaction was a major influence on the field.

Olefin metathesis

Yves Chauvin's mechanism (1971) was theoretical; Schrock and Grubbs developed catalysts (1990s+) that made it practical. By 2005, Nobel; by 2010, used in many drug syntheses (RCM for macrocycles).

Asymmetric synthesis

The development of asymmetric methods (Knowles, Noyori, Sharpless, Nobel 2001) was driven by drug synthesis needs. Each new asymmetric reaction was first explored in total synthesis applications.

C-H activation

Modern C-H activation methods are being explored in total synthesis. Sames, Yu, and other groups use natural product targets as testing grounds for new C-H activation reactions.

Photoredox

Visible-light photoredox catalysis (Nicewicz, MacMillan, Stephenson, ~2008-2015) has been applied to many natural product syntheses, often shortening sequences and enabling new bond formations.

In each case, total synthesis is the application that demonstrates the new chemistry. Without natural product targets, many of these methods wouldn't have been developed.

38.22 The synthesis-biology connection

Synthesis enables biology, and biology enables synthesis:

Synthesis enables biology

• Studying enzyme mechanism: synthesize the substrate analog with isotopic labels.
• Studying receptor binding: synthesize structural variants (SAR).
• Studying signal transduction: synthesize fluorescent probes.
• Drug development: synthesize candidate drugs.

Biology enables synthesis

• Engineered enzymes for asymmetric catalysis.
• Bacterial metabolism for producing intermediates.
• Whole-organism biosynthesis (yeast, E. coli) for natural products.

Examples

• Erythromycin biosynthesis is now better understood thanks to synthetic studies.
• Antibiotic discovery uses combinations of synthesis and bioassays.
• Drug development: synthetic chemistry meets cell biology meets clinical trials.

The synthesis-biology interface is rich and productive.

38.23 Building blocks and chiral pool synthesis

A common strategy: start from a chiral natural product and build outward.

Common chiral pool starting materials

• Amino acids (chiral; L-form): Glu, Asp, Phe, Cys.
• Sugars: D-glucose, D-mannose; chiral with multiple stereocenters built-in.
• Terpenes: (-)-menthol, (+)-α-pinene, citronellal.
• Alkaloids: cinchonidine, quinine.
• Hydroxy acids: tartaric acid, malic acid, lactic acid.

Why chiral pool

These are commercially available, cheap, and pure. Starting from them saves the asymmetric synthesis step. The challenge: redesigning the target's carbon skeleton to fit the chiral pool building block.

Examples

• Many terpenoid syntheses start from menthol or pinene (chiral natural products).
• Sugar-based drug syntheses (e.g., zanamivir, neuraminidase inhibitor) start from D-glucose.
• Amino acid-based syntheses for many drugs.

Even with modern asymmetric catalysis, chiral pool synthesis remains useful for cost-effective production.

38.24 Convergent vs linear synthesis: the math

For an n-step synthesis with each step at 80% yield:

Linear: each step in series. Overall yield = 0.8^n. - 1 step: 80%. - 5 steps: 33%. - 10 steps: 11%. - 20 steps: 1%.

Convergent: parallel branches converging. If two branches each take n/2 steps, then merge in 1 step: - 5 steps total (2+2+1): 0.8^5 = 33% per branch; final coupling × overall 33% × 33% × 80% = 9%. - BUT each branch uses less starting material; the wasted material is in only one branch.

For complex molecules (n > 10), convergent synthesis often gives more total product despite a smaller-looking yield. The math favors splitting the work.

When to use convergent

• Target has clear substructures (rings, chains).
• Couplings between substructures are robust.
• Each branch has accessible starting materials.

Limitations

• Final coupling step may be hard.
• More planning required.
• Can be wasteful if branches don't combine cleanly.

In practice, modern total synthesis is almost always convergent for complex targets.

38.25 Stereocontrol strategies

For molecules with multiple stereocenters, controlling each one is critical.

Approach 1: Chiral pool starting material

Start from a chiral natural product; the stereocenters are already in place. Build outward.

Approach 2: Asymmetric catalysis

Use a chiral catalyst (Sharpless, Knowles, Noyori, modern catalysts) to install each new stereocenter selectively.

Approach 3: Substrate control

The existing stereocenters direct the new ones via Felkin-Anh, chelation, or other models. Common in natural product synthesis.

Approach 4: Chiral auxiliary

Attach a chiral group (Evans oxazolidinone, Oppolzer's sultam) to direct the reaction; remove the auxiliary at the end.

Approach 5: Resolution

Make the racemate; resolve via diastereomer formation, chiral chromatography, or enzymatic resolution.

Approach 6: Late-stage diversification

Make the framework first; install stereocenters in modular steps with chiral catalysts.

Modern total syntheses often use multiple approaches in combination.

38.26 Protecting groups: when and why

Total syntheses often need protecting groups — temporary masking of functional groups to prevent unwanted reactivity.

Common protecting groups

For alcohols (-OH): - TMS (trimethylsilyl), TBS (tert-butyldimethylsilyl): protect OH; remove with F⁻ (TBAF, HF). - THP (tetrahydropyranyl): acid-labile protection. - MOM (methoxymethyl): acid-labile. - Bn (benzyl): hydrogenated off (H₂/Pd). - Acyl (Ac): hydrolysis off.

For amines (-NH₂, -NHR): - Boc (tert-butoxycarbonyl): acid-labile. - Cbz (benzyloxycarbonyl): hydrogenated off. - Fmoc (fluorenylmethyloxycarbonyl): base-labile (piperidine).

For carboxylic acids: - Ester (methyl, ethyl, benzyl, tert-butyl): different removal conditions. - Trimethylsilyl ester: F⁻ deprotection.

For carbonyls: - Acetals/ketals: protect aldehyde/ketone; remove with acid hydrolysis. - Enol ethers: similar.

When to use

• The functional group would interfere with a planned reaction.
• The reaction conditions are too harsh for the unprotected group.
• Selective deprotection is needed (e.g., Boc on one amine, Fmoc on another).

Strategic considerations

• Orthogonal protection: different groups, different conditions; can selectively remove.
• Atom economy: protecting groups add steps and waste.
• Modern preference: minimize protection by using selective reactions or chiral catalysts that tolerate functional groups.

Modern total synthesis tries to minimize protecting group steps; classical syntheses (1950s-1980s) used many.

38.27 Industrial vs academic total synthesis

Industrial and academic synthesis have different priorities:

Academic synthesis

• Goal: prove a structure, develop new chemistry, train students.
• Constraints: time (~5 years per synthesis), funding (research grants).
• Yield: often <1%; not optimized.
• Steps: 20-50+ for complex targets.
• Reagents: any that work; expense not always primary concern.

Industrial pharmaceutical synthesis

• Goal: kg or ton scale of pure drug for clinical trials and market.
• Constraints: cost, time-to-market, scalability, environmental impact.
• Yield: optimized to >50% per step typically.
• Steps: minimized (often 5-15).
• Reagents: cheap, recyclable, environmentally friendly preferred.

Commercial natural product extraction vs synthesis

For natural products with biological activity: - If extraction is feasible (sufficient natural source): often cheaper than total synthesis. - If natural source is rare: total synthesis or semi-synthesis. - Taxol: now made by semi-synthesis (extracted baccatin → Taxol via 4 steps). - Vincristine, vinblastine: extracted from Madagascar periwinkle (small amounts). - Artemisinin: extracted from sweet wormwood + semi-synthesis from yeast.

The chemistry of academic synthesis often informs industrial process chemistry.

38.28 Targets that have defied total synthesis

Some natural products are still challenges:

Maitotoxin

A marine natural product (~1990 isolated). Structure published in 1996. Largest non-polymeric natural product known. So far, no total synthesis (~140 stereocenters, ~~32 fused rings).

Palytoxin

A marine natural product; isolated in 1971. Y. Kishi's total synthesis (1989) was a 64-step tour-de-force. The synthesis used over 100 named reactions; remains a benchmark.

Several alkaloids

Some indole alkaloids and complex polyketides have resisted total synthesis for decades. Nature builds them efficiently with enzymes; chemists often need much longer routes.

Why so hard?

• Many stereocenters.
• Many functional groups.
• Convergent assembly hard.
• Each step needs precise stereo and regiochemistry.

These remaining challenges drive new chemistry development.

38.29 Synthesis as creativity

Total synthesis is sometimes called "the art of organic chemistry." Why?

1. Aesthetic value: an elegant synthesis is beautiful, like a symphony or painting.
2. Originality: a clever disconnection or new method gets recognized.
3. Recognition: master synthesis chemists are revered in the chemistry community.
4. Prizes: many Nobel Prizes have been awarded for synthesis (Woodward, Corey, Sharpless, Knowles, Noyori, Heck, Negishi, Suzuki, Grubbs, Schrock, Chauvin, Bertozzi).

Like art, synthesis combines technical skill with creative vision. The chemist designing a new route is making artistic choices (which disconnections, what order, which methods).

This artistic dimension is part of why synthesis remains exciting after a century of practice.

38.30 The future of total synthesis

What's coming next?

AI-driven retrosynthesis

Machine learning will continue to improve. Within ~10 years, AI may propose better synthesis routes than human chemists for many targets.

Automated synthesis

Robot platforms execute synthesis steps autonomously. A target structure → automated synthesis → product. Already in development; commercialization expected in years.

Continuous-flow synthesis

Most synthesis becomes continuous-flow rather than batch. Better thermal control, scalability, automation.

Biocatalysis dominance

Engineered enzymes will replace chemical catalysts for many transformations. Greener, milder, more selective.

Targeted molecular design

Computer-aided design of new drug candidates → synthesis → testing. Much faster cycle than empirical drug discovery.

Sustainable synthesis

Atom-economical reactions, water solvents, recyclable catalysts, renewable feedstocks. Environmental constraints will drive innovation.

The art of synthesis is here to stay; the tools and methods will evolve.

38.31 Conclusion: the chemistry is yours

After 38 chapters of organic chemistry, you have: - A foundational understanding of bonding, structure, mechanism, and stereochemistry. - Mastery of the major reaction classes (substitution, elimination, addition, aromatic, carbonyl). - Familiarity with bioorganic and pharmaceutical applications. - Awareness of advanced topics: oxidation/reduction, organometallic catalysis, total synthesis, pericyclic reactions, green chemistry.

This foundation lets you: - Read modern chemistry literature. - Solve novel synthesis problems. - Continue learning chemistry on your own. - Pursue careers in research, industry, medicine, or teaching.

Chapter 39 covers pericyclic reactions and Woodward-Hoffmann rules — a more theoretical topic that explains many of the syntheses we've discussed. Chapter 40 closes the book with green chemistry, flow chemistry, and modern synthesis — what's coming next in the field.

The chemistry is yours. What you build with it is up to you.

38.32 Common synthesis problem types

Total synthesis can take many forms. Common problem types:

Type 1: Linear chain synthesis

Build a long carbon chain step by step. Examples: pheromones, fatty acids, simple terpenes.

Methods: SN2, Wittig, Heck, Suzuki, hydroboration.

Type 2: Ring synthesis

Build a ring from acyclic precursors. Examples: cyclopentane synthesis (5-exo-trig); cyclohexene (Diels-Alder); macrocycles (RCM).

Methods: cyclization (intramolecular SN2, aldol, Diels-Alder, RCM, etc.).

Type 3: Polycyclic synthesis

Build fused rings. Examples: steroids, terpenoids, alkaloids.

Methods: cascade reactions, biomimetic cyclizations, sequential ring closures.

Type 4: Heterocyclic synthesis

Build nitrogen, oxygen, or sulfur-containing rings. Examples: indole, pyridine, purine, benzofuran.

Methods: aza-Michael, Friedländer synthesis, Hantzsch synthesis, etc.

Type 5: Stereodefined synthesis

Build with specific stereochemistry. Examples: chiral drugs, natural products with specific configurations.

Methods: asymmetric catalysis, chiral auxiliaries, chiral pool, kinetic resolution.

Type 6: Macromolecular synthesis

Build polymers or large biomolecules. Examples: polypeptides, polysaccharides, polynucleotides.

Methods: solid-phase synthesis (SPPS, automated DNA), polymerization (radical, ROMP).

Type 7: Total synthesis

Build a complex natural product from simple starting materials. Examples: Taxol, vitamin B12, brevetoxin, palytoxin.

Combination of all the above techniques.

Take-home

Each problem type has its own toolkit. Modern synthesis combines all of them. The chemistry of this textbook gives you the foundation; total synthesis is the integration.

38.33 The Hippocratic oath of synthesis

A reflection on the responsibilities of a synthesis chemist:

• Synthesize what you can verify: don't make claims that can't be tested.
• Honest yields: report yields accurately.
• Reproducibility: write protocols that others can follow.
• Safety: think about every reaction's hazards before running it.
• Disposal: minimize waste; follow regulations.
• Authorship: give credit where due.
• Collaboration: be honest in collaborations.

These ethical considerations are part of being a synthesis chemist. The chemistry is powerful; with it comes responsibility.

38.34 The challenge for the next generation

Today's challenges in synthesis:

Climate-friendly synthesis

Move away from petroleum feedstocks; use bio-based or CO₂-derived starting materials.

Sustainable manufacturing

Reduce waste, energy, water use in industrial chemistry.

New drug targets

Many diseases (Alzheimer's, ALS, cancers) need new drugs. Synthesis chemistry contributes.

Personalized medicine

Custom drug synthesis for individual patients (currently rare; future possibility).

Antibiotic discovery

Resistance is rising; new antibiotics are needed. Synthesis chemistry can help.

Sustainable plastics

Polyolefins and PET are useful but environmentally problematic. New, biodegradable polymers from sustainable sources.

These challenges await the next generation of synthesis chemists. The chemistry foundation you've gained from this textbook is the starting point.

38.35 Notable syntheses by decade

1900s-1920s: Organic chemistry's foundations

• Sertürner's morphine isolation (1804) — pre-synthesis era.
• Fischer's amino acid syntheses (1900s) — early systematic synthesis.
• Wöhler's urea synthesis (1828) — disproved vitalism.

1930s-1940s: Mechanism era

• Robinson's tropinone synthesis (1917) — biomimetic synthesis.
• Diels and Alder discover Diels-Alder (1928).
• Reppe acetylene chemistry (1930s).

1950s-1960s: Woodward era

• Woodward's strychnine synthesis (1954).
• Woodward's reserpine synthesis (1956).
• Eschenmoser-Woodward vitamin B12 (1960-1972).
• Corey introduces retrosynthesis (1969).

1970s-1980s: Strategic synthesis

• Sharpless asymmetric epoxidation (1980).
• Knowles' L-DOPA (1974, commercial).
• Total synthesis of palytoxin (Kishi, 1989).
• Sonogashira (1975), Heck (1968) coupling reactions.

1990s-2000s: Cross-coupling era

• Suzuki coupling (1979), Stille (1977), Negishi (1977).
• Buchwald-Hartwig amination (mid-1990s).
• Grubbs metathesis catalysts (1996+).
• Many natural product syntheses using new methods.

2010s-2020s: Modern era

• Asymmetric catalysis becomes routine.
• C-H activation matures.
• Photoredox catalysis emerges.
• Biocatalysis adopted in pharma.
• AI-aided synthesis.

Each decade's chemistry built on the previous; the chemistry of this textbook reflects ~200 years of cumulative discovery.

38.36 The role of yield in synthesis

Yield is sometimes mistakenly equated with synthetic value:

High yield ≠ best synthesis

A 99%-yield 50-step synthesis is worse than an 80%-yield 5-step synthesis (from total throughput perspective).

Why yield matters

• Cost: more material per step.
• Time: fewer reruns.
• Waste: less waste per product.

Why yield isn't everything

• A 30% yield route in 5 steps may be much better than a 80% yield route in 30 steps.
• Modern industrial chemistry optimizes overall route efficiency, not just per-step yield.

Modern strategies

• Use telescoping (combine multiple steps without isolation).
• Use chiral catalysts for asymmetric step (often 80-95% yield, high ee).
• Use enzymes for specific transformations (often >95% yield).
• Avoid protecting groups when possible.
• Use convergent synthesis for complex targets.

The art of synthesis includes optimizing the overall efficiency, not just any single step.

38.37 The synthesis-chemistry-biology spiral

A productive cycle: 1. Biology: identifies a biologically active natural product. 2. Chemistry: total synthesis. 3. Synthesis enables: structural variants (SAR). 4. Variants: tested for activity. 5. Activity-structure relationships: feed back to biology. 6. New biology: receptor identified, etc. 7. Cycle: continues.

Examples

• Penicillin: discovered (Fleming, 1928), structure determined, total synthesis (Sheehan, 1957), variants (semisynthetic penicillins, cephalosporins, carbapenems). Each new variant addresses different bacterial targets.
• Statins: discovered (mevinolin from fungi, 1970s), structure characterized, total synthesis (1980s), modern variants (atorvastatin, rosuvastatin, etc.). Hundreds of millions of patients now treated.
• Cisplatin: discovered (1965, accidentally), variants (carboplatin, oxaliplatin), each more selective. Cancer treatment improved.

Modern integration

The chemistry-biology spiral now includes computational drug design (AlphaFold, docking, ML) and high-throughput screening. Synthesis chemistry is integrated with biology, computer science, and medicine.

38.38 Tools of the synthesis chemist

Beyond the chemistry, modern synthesis chemists use:

Software

• ChemDraw: drawing structures and reactions.
• Reaxys / SciFinder: literature search.
• Synthesis planning software: Chematica, IBM RXN, Synthia.
• NMR processing: MestReNova, TopSpin, ACD/Labs.
• DFT/computational: Gaussian, ORCA.
• Spreadsheets: yields, kinetics, ee.

Equipment

• NMR spectrometer: 400-700 MHz (research labs).
• HPLC: chiral and achiral columns.
• GC-MS: monitoring reactions, identifying products.
• IR: ATR-FTIR for quick analysis.
• Polarimeter: for [α]_D measurements.
• Mass spectrometer: HRMS for exact mass.
• X-ray diffractometer: for crystal structure determination.
• Glovebox: for air/moisture-sensitive reactions.

Lab supplies

• Glassware: round-bottom flasks, condensers, distillation apparatus.
• Heating mantles, oil baths, ice baths: for temperature control.
• Magnetic stirrers: ubiquitous.
• Vacuum pumps, rotary evaporators: for solvent removal.
• Chromatography columns: silica gel for purification.

Materials

• Reagents: from Sigma, Alfa Aesar, TCI, Combi-Blocks.
• Catalysts: Strem, Sigma; many specialty catalysts.
• Solvents: anhydrous when needed.
• Drying agents: MgSO₄, Na₂SO₄, molecular sieves.

Personal protective equipment

• Lab coats: standard.
• Goggles: always when in lab.
• Gloves: nitrile typically.
• Fume hoods: for any volatile or hazardous reagent.
• Schlenk lines: for inert atmosphere work.

The chemistry of synthesis is also the discipline of doing it safely.

38.39 The synthesis as a creative product

A synthesis paper communicates more than just the recipe: - The strategic insight (why this disconnection?). - The technical challenge (what was hard?). - The contribution (what's new?). - The training (next-generation chemists learn from it).

Reading a great synthesis paper is like reading a great novel: you see the author's voice, their priorities, their judgment. Each step is a choice; the cumulative choices reveal the author's chemistry philosophy.

For example: - Woodward's work: classical, methodical, built one ring at a time. - Corey's work: strategic, systematic, often used the most modern methods. - Nicolaou's work: ambitious, multi-disciplinary, integrated biological motivation. - Trost's work: clever, often using unusual disconnections. - Modern groups: AI-assisted, biocatalytic, photoredox.

Each chemist contributes their style. The art of synthesis is partly individual; the great chemists each had a recognizable voice.

38.40 The synthesis lab in 2050

Looking forward 25 years:

• AI designs syntheses; chemists evaluate and execute.
• Robots do most lab work; chemists supervise and troubleshoot.
• Biocatalysis dominates many transformations.
• Photoredox and electrochemistry are routine.
• C-H activation is the standard for late-stage diversification.
• Continuous flow replaces batch in most cases.
• Real-time monitoring with NMR/IR/MS in flow.
• Greener solvents (water, biomass-derived).
• Renewable feedstocks (CO₂, biomass).
• AI-driven drug discovery with synthesis as the bottleneck.

The chemistry of this textbook is the foundation. The future of synthesis is being built on it now.

38.41 Diversity in synthesis chemistry

The history of synthesis is dominated by certain demographics, but it's diversifying:

• Women in synthesis: Tu Youyou (Nobel 2015), Carolyn Bertozzi (Nobel 2022), Jennifer Doudna (Nobel 2020 for CRISPR; biology), Frances Arnold (Nobel 2018 for directed evolution).
• Global synthesis: Asian chemists are now major contributors (Japan, China, India). Latin American and African chemistry communities growing.
• Industrial-academic partnerships: many breakthrough syntheses come from industry-academia collaborations.
• Open-access publishing: makes synthesis more accessible.

Diversity strengthens chemistry by bringing different perspectives and questions. The next generation of synthesis chemists will be more diverse than the previous.

38.42 The story of one molecule: penicillin

A single example of synthesis history:

1928: Alexander Fleming discovers penicillin (mold + bacteria killing zone). 1939-1941: Florey and Chain isolate and characterize penicillin (Oxford); test in humans. 1942: Mass production for World War II. 1945: Nobel Prize to Fleming, Florey, Chain. 1957: J. C. Sheehan completes the total synthesis of penicillin V (10+ years of work). 1960s: Semisynthetic penicillins (ampicillin, amoxicillin) developed. 1970s: Cephalosporins, similar mechanism. 1980s+: Carbapenems for resistant bacteria. Today: Penicillin and its descendants treat billions of patients each year. Antibiotic resistance challenges ongoing.

Each step in this story is chemistry — discovery, structure determination, total synthesis, semisynthesis, modification. The art of synthesis is interwoven with the history of medicine.

38.43 Common mistakes in total synthesis

Common Mistake 38.1 — Underestimating retrosynthetic complexity. A 5-step proposal often takes 15 steps in practice; some reactions don't work as planned.

Common Mistake 38.2 — Using protecting groups unnecessarily. Modern strategy: avoid protection if possible.

Common Mistake 38.3 — Not planning for stereo control. Each new stereocenter requires explicit thought; the wrong configuration ruins everything.

Common Mistake 38.4 — Believing literature yields blindly. Often, a published yield is the best yield achieved; routine practice may be lower.

Common Mistake 38.5 — Ignoring functional group compatibility. A reaction works in isolation but fails in a complex molecule with other functional groups.

Common Mistake 38.6 — Not testing the route on simple model substrates first. Optimize the chemistry on a simple substrate before applying to the complex target.

Common Mistake 38.7 — Forgetting workup, purification, and characterization. Each step requires these; cumulative time is significant.

38.44 Spectroscopy in synthesis monitoring

After each step, the chemist confirms the structure of the intermediate by: - ¹H NMR (most informative). - ¹³C NMR. - Mass spec (HRMS for exact mass). - IR (for key functional groups). - Optical rotation (for chiral compounds). - Melting point (for known compounds).

Modern automated synthesizers integrate inline NMR, IR, and HPLC for real-time monitoring. The chemist sees the reaction progress (substrate consumption, product formation) without sampling.

This is a major time-saver for complex syntheses.

38.45 Final summary

Total synthesis is the integration of organic chemistry into something useful: complex molecules with biological or material function.

Key takeaways: - Use retrosynthesis to plan the route. - Choose strategic disconnections. - Apply all the chemistry of this textbook. - Use modern catalysis (Pd, asymmetric, biocatalytic). - Verify each step by spectroscopy. - Optimize for yield, scalability, sustainability.

The chemistry is the foundation; total synthesis is what you can do with it.

38.46 What this chapter has taught

By the end of Chapter 38, you should: - Understand retrosynthesis as the strategic framework. - Be familiar with major total syntheses (artemisinin, strychnine, Taxol, vitamin B12, brevetoxin, palytoxin, oseltamivir, atorvastatin). - Know the role of asymmetric methods in modern synthesis. - Recognize the integration of biology, computer science, and engineering with synthesis. - Appreciate the artistic dimension of synthesis design. - Be able to plan a multi-step synthesis using the methods of this textbook.

This is the capstone for the synthesis content of the book. The chemistry is comprehensive; what remains is application and continued learning.

38.47 Looking ahead

Chapter 39: pericyclic reactions and Woodward-Hoffmann rules — the theoretical underpinning of many synthetically important reactions (Diels-Alder, sigmatropic rearrangements, electrocyclics).

Chapter 40: green chemistry, flow chemistry, biocatalysis, AI-aided synthesis — the future of organic chemistry.

These last two chapters complete the textbook. After them, you have a comprehensive foundation in modern organic chemistry.

38.48 The chemistry-society interface

Total synthesis isn't done in a vacuum:

Ethical considerations

• Drug development: who pays, who benefits?
• Patent landscape: open vs proprietary chemistry?
• Environmental impact: industrial chemistry's footprint?

Public engagement

• Communicating chemistry to the public.
• Open-access publishing.
• STEM education and outreach.

Policy

• Regulatory framework (FDA, EPA).
• Patent law affecting drug development.
• International standards (REACH, ICH).

These broader considerations shape how synthesis chemistry is practiced. The next generation of chemists will need to engage with these issues.

38.49 The chemistry never stops

The history of organic chemistry has been one of accelerating progress:

• 1828: Wöhler's urea synthesis (~1 simple molecule per decade).
• 1900s: ~10 simple syntheses per year.
• 1950s: ~100 simple syntheses per year.
• 2000s: thousands per year.
• 2020s: AI-aided design, automated synthesis; tens of thousands.

Each generation builds on the previous. The chemistry of this textbook captures the cumulative achievement of ~200 years.

What's coming next? Hard to predict, but likely: - AI-driven discovery of new reactions. - Better catalysts for difficult transformations. - Integration of synthesis with biology, computing, engineering. - New molecules with new functions (drugs, materials, sensors).

The chemistry is yours. The future is being made now.

38.50 Final reflections

The chemistry of this textbook gives you the foundation for understanding and creating molecules. The methods of total synthesis show what can be done with this foundation.

The next chapters (39: pericyclic reactions; 40: green chemistry) round out the picture. After Chapter 40, you have the comprehensive picture of modern organic chemistry.

The art of synthesis is the chemistry's culmination. From simple alkanes (Ch 5) to complex natural products (Ch 38), the same principles apply. Mastering them lets you build essentially any molecule.

The chemistry is yours.

38.51 Summary

1. Total synthesis is the construction of complex molecules from simple starting materials, integrating every chapter of organic chemistry.
2. Artemisinin is a sesquiterpene endoperoxide antimalarial; Tu Youyou won the 2015 Nobel Prize for its discovery.
3. Strategic disconnections identify which bonds to break in retrosynthesis.
4. Convergent synthesis is preferred over linear; high overall yield.
5. Stereocontrol uses chiral pool, asymmetric methods, or chiral auxiliaries.
6. Schmid synthesis (1983): 14-step total synthesis of artemisinin from (+)-citronellal. ~5% yield.
7. Modern industrial production: extraction from sweet wormwood + semi-synthesis from yeast-engineered artemisinic acid.
8. Master synthetic chemists: Woodward (Nobel 1965), Corey (Nobel 1990), Nicolaou (modern), Tu Youyou (Nobel 2015).
9. Modern tools: AI-guided synthesis, flow chemistry, biocatalysis, photoredox, C-H activation.
10. What "art" means: design choice, elegance, surprise, stereocontrol, efficiency.

Chapter 39 turns to pericyclic reactions and Woodward-Hoffmann rules — a more theoretical topic that underlies many of the synthesis strategies discussed here.